Future

 

The FTSE-250 listed global specialist media platform Future, has this morning announced that its CEO is to stand down and return to the US in 2025. There’s no suggestion of anything untoward here, the 12 month notice period will be fulfilled and an orderly transition should now follow. Whilst the note adds that the growth acceleration strategy he masterminded is now well underway, beyond the marked gains of April '24 the stock's performance has been lacking since. With that in mind, is today’s 12% slide in the Future share price warranted?

 

Mothercare

 

The brand that once sat on every high street in the UK still exists although in a rather different shape. Yesterday the company announced news of a Joint Venture and a new funding agreement, which were sufficient for auditors to finish their reports and get accounts published this morning. That’s a few weeks late so the stock had been suspended since the start of the month, but trading resumed today and the combined effect of these updates was well received with the Mothercare share price jumping by as much as 65% shortly after the bell, although some of that upside was given back.

 

British American Tobacco

 

The tobacco giant issued an update today regarding its Canadian subsidiary which is currently operating under creditor protection as it works through litigation in the country. Good progress is evidently being made in finding a resolution, although this process is now in its fifth year of running. With the BATS share price dipping around 3% in early trade, the inference could be that investors had hoped to see more progress by now.

 

Today’s most read stories

 

Boohoo Group Business update

OptiBiotix Health Response to publication of circular

Future Directorate Change